NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
Closes in 7 days
National Institutes of Health
NIH Director’s New Innovator Award Program (DP2 Clinical Trial Optional)
Biomedical Engineering, Biology and Public Health DP2 research award from National Institutes of Health
Closed on Monday, Aug 17
Up to $2,375,000
About
The NIH Common Fund supports exceptionally creative early-stage investigators pursuing bold, high-impact biomedical or behavioral research without requiring preliminary data.
Eligibility
Career stage: Early independent researcher
Host location: United States
Reviewed Sep 24, 2026. Check the funder’s full conditions before applying.
Early Stage Investigators proposing unusually innovative, high-impact work relevant to the NIH mission; single principal investigator and at least 25 percent research effort required.
Topics
Related funding
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
Closes Jan 7, 2028National Institutes of HealthMcKnight Neurobiology of Brain Disorders Award — 2027
Closes in 6 daysMcKnight Endowment Fund for Neuroscience
More from National Institutes of Health
Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)
Closes in 7 daysNational Institutes of HealthNeuromodulation/Neurostimulation Device Development for Mental Health Applications (R21 Clinical Trial Not Allowed)
Closes in 7 daysNational Institutes of HealthDevelopment of Biomarkers or Composite Biomarkers for Neurological and Neuromuscular Disorders (R61/R33 - Clinical Trial Optional)
Closes Oct 20National Institutes of HealthComputational Approaches to Curation at Scale for Biomedical Research Assets (R01 Clinical Trial Not Allowed)
Closes Jan 15, 2027National Institutes of Health
Source: commonfund.nih.gov